Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Immuron Ltd Regulatory Filings 2008

Nov 19, 2008

35121_rns_2008-11-19_46d28bae-6007-461c-bcab-9f689eff5efc.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

20 November 2008

The Manager The Company Announcement Office Australian Stock Exchange Limited Sydney NSW

Dear Sir Appendix 3B

Attached is an Appendix 3B in respect of a recent issue of shares for cash, together with an issue of shares to a Director as approved by members at the Annual General Meeting held on 19 November 2008.

Yours faithfully Graeme Stevens

Company Secretary

ABN 80 063 114 045 AUSTRALIA Level 1, 39 Leveson Street
North Melbourne VIC 3051 Tel (61) 3 9018 4880 Fax (61) 3 9018 4881

USA The Empire State Building 350 Fifth Avenue 59th Floor New York, N.Y. 10118
Tel 646 402 5289 Fax 646 390 3238

www.anadis.com www.travelan.com

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement. application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

Anadis Limited

ABN

80 063 114 045

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\mathbf{1}$ +Class of +securities issued or to be | Ordinary shares issued

  • $\overline{2}$ Number of +securities issued or to be issued (if known) or maximum number which may be issued
  • Principal terms of the +securities (eg, $\overline{3}$ if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates payment; if +convertible for securities, the conversion price and dates for conversion)

8,510,950

Issued as fully paid ordinary shares

  • See chapter 19 for defined terms.

24/10/2005 Appendix 3B Page 1

Do the +securities rank equally in all $\overline{4}$ YES respects from the date of allotment with an existing +class of quoted +securities?

If the additional securities do not rank equally, please state:

  • the date from which they do $\bullet$
  • the extent to which they $\bullet$ participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

5 Issue price or consideration Issue price of \$0.05 per share

purposes, and

November 2008.

7,705,950 shares issued for working capital

805,000 issued to a Director as approved at the Annual General Meeting held on 19

  • Purpose of the issue 6 (If issued as consideration for the acquisition of assets, clearly identify those assets)
  • $\overline{7}$ Dates of entering +securities into uncertificated holdings or despatch of certificates

20 November 2008

8 Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

Number +Class
134,411,896 Ordinary shares

+ See chapter 19 for defined terms.

Number + Class
9 Number
+ class
of
all
and
*securities not quoted on ASX
831,820 Ordinary shares
(including the securities in clause 2)
if applicable)
162,500
4,913,370
4,913,370
Options ANXAJ
Options ANXAO
Options ANXAZ
$\Omega$

Dividend policy (in the case of a Not applicable.
trust, distribution policy) on the increased capital (interests) 10

Part 2 - Bonus issue or pro rata issue

11 security
holder
Is.
approval
required?
12 Is the issue renounceable or non-
renounceable?
13 Ratio in which the "securities will
be offered
14 + Class of + securities to which the
offer relates
15 + Record
date
determine
to
entitlements
16 Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17 Policy for deciding entitlements in
relation to fractions
18 Names of countries in which the
entity has *security holders who
will not
be
sent new issue
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing
date
for
receipt
of
acceptances or renunciations

$1/1/2003$

+ See chapter 19 for defined terms.

Appendix 3B New issue announcement

20 Names of any underwriters
21 Amount of any underwriting fee or
commission
22 Names of any brokers to the issue
23 Fee or commission payable to the
broker to the issue
24 Amount of any handling fee payable
to brokers who lodge acceptances
renunciations on behalf of
or
+ security holders
25 If the issue
is contingent
on
*security holders' approval, the date
of the meeting
26 Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent to
persons entitled
27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do + security holders sell their
entitlements in full through a
broker?
31 How do + security holders sell part
of their entitlements through a
broker and accept for the balance?

+ See chapter 19 for defined terms.

  • 32 How do +security holders dispose of their entitlements (except by sale through a broker)?
  • 33 +Despatch date
그 사람들은 아이들이 아이들은 아이들이 없었다. 이 사람들은 아이들이 아이들이 아이들이 아니다.

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of securities (tick one)

$(b)$

  • $(a)$ Securities described in Part 1. Ιx
  • All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders 36 If the 'securities are 'equity securities, a distribution schedule of the additional *securities setting out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$ $10,001 - 100,000$ 100,001 and over 37 A copy of any trust deed for the additional +securities

1/1/2003

+ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

  • 38 Number of securities for which +quotation is sought
  • 39 Class of +securities for which quotation is sought
  • Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

If the additional securities do not rank equally, please state:

  • the date from which they do
  • the extent to which they $\bullet$ participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • $\bullet$ the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
  • $41$ Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

42 Number and +class of all +securities quoted on ASX (including the securities in clause 38)

+Class

40

  • See chapter 19 for defined terms.

Quotation agreement

  • *Quotation of our additional *securities is in ASX's absolute discretion. ASX may $\mathbf{1}$ quote the *securities on any conditions it decides.
  • $\mathcal{D}$ We warrant the following to ASX.
  • The issue of the 'securities to be quoted complies with the law and is not for an illegal purpose.
  • There is no reason why those *securities should not be granted *quotation.
  • An offer of the 'securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any *securities to be quoted and that no-one has any right to return any 'securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the $\bullet$ *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the 'securities be quoted.
  • $\overline{\mathbf{3}}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • We give ASX the information and documents required by this form. If any $\overline{4}$ information or document not available now, will give it to ASX before 'quotation of the 'securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

......Date: 20 November 2008 ..................................

Print name: Graeme Stevens

Company Secretary ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

Sign here:

+ See chapter 19 for defined terms.

24/10/2005 Appendix 3B Page 7